title: Impaired NADPH oxidase activity in peripheral blood lymphocytes of galactosemia patients.
abstract: Galactosemia is an autosomal recessive disorder with a wide range of clinical abnormalities. Cellular oxidative stress is considered as one of the pathogenic mechanisms of galactosemia. In this study, we examined the activity of NADPH oxidase (NOX), a major superoxide-generating enzyme system, in peripheral blood lymphocytes (PBL) from galactosemia patients. PBL were isolated from galactosemia patients and healthy control subjects and used for cell culture studies and biochemical assays. PBL were cultured in the presence or absence of galactose or galactose-1-phosphate (Gal-1-P), and enzyme activities and/or gene expression of NOX, catalase, superoxide dismutase (SOD) and glutathione peroxidase (GPx) were measured in the cell homogenates. PBL isolated from galactosemia patients showed significantly reduced (P < 0.01) activities of catalase and GPx; however SOD activity remained unaltered. Galactosemia patients were found to have significantly (P < 0.01) increased levels of malondialdehyde (MDA) in blood lymphocytes. Enzymatic activity of NOX was significantly (P < 0.001) reduced in galactosemia patients; however, Western blotting revealed that NOX-1 protein was not significantly altered. Interestingly, levels of NOX activity in lymphocytes isolated from galactosemia patients significantly increased but remained subnormal when cultured in galactose-deficient medium for two weeks, indicating a galactose-mediated inhibition of NOX. Lymphocytes isolated from control subjects were found to have significantly (P < 0.01) reduced NOX activity when cultured in the presence of galactose or Gal-1-P for two weeks. These results show that galactose-induced cellular oxidative stress is not NOX mediated. However, impairment of the NOX system might be responsible for some of the clinical complications in galactosemia patients.
authors.affiliation: Department of Pediatrics, Faculty of Medicine, Kuwait University, Kuwait.
authors.forename: Mazen
authors.initials: M
authors.lastname: Al-Essa
authors.forename: Gursev S
authors.initials: GS
authors.lastname: Dhaunsi
authors.forename: Wafa'a
authors.initials: W
authors.lastname: Al-Qabandi
authors.forename: Islam
authors.initials: I
authors.lastname: Khan
mesh_terms: D000975:Antioxidants / Q000378:metabolism; D015153:Blotting, Western; D016022:Case-Control Studies; D002469:Cell Separation; D002478:Cells, Cultured; D002675:Child, Preschool; D005690:Galactose / Q000494:pharmacology; D005693:Galactosemias / Q000097:blood* / Q000201:enzymology*; D005695:Galactosephosphates / Q000378:metabolism / Q000494:pharmacology; D005954:Glucosephosphate Dehydrogenase / Q000378:metabolism; D006801:Humans; D007223:Infant; D015227:Lipid Peroxidation / Q000187:drug effects; D008214:Lymphocytes / Q000187:drug effects / Q000201:enzymology / Q000473:pathology; D008315:Malondialdehyde / Q000378:metabolism; D000074624:NADPH Oxidase 1; D019255:NADPH Oxidases / Q000097:blood* / Q000378:metabolism; D009573:Nitrites / Q000378:metabolism; D010750:Phosphoproteins / Q000378:metabolism
chemical_list: D000975:Antioxidants; D005695:Galactosephosphates; D009573:Nitrites; D010750:Phosphoproteins; C079789:neutrophil cytosol factor 67K; C029973:galactose-1-phosphate; D008315:Malondialdehyde; D005954:Glucosephosphate Dehydrogenase; D000074624:NADPH Oxidase 1; D019255:NADPH Oxidases; C402799:NOX1 protein, human; C086986:CYBA protein, human; C060505:neutrophil cytosolic factor 1; D005690:Galactose
keywords: NADPH oxidase; galactosemia; lymphocytes